SARCOMA CONNECT has summarised highlights of the recent ESMO 2019 meeting for you
SARCOMA CONNECT has summarised highlights of the recent ESMO 2019 meeting for you
Sebastian Bauer (MD) underwent his medical training at the University of Würzburg, Germany and his resisdency and medical oncology fellowship at the University of Duisburg-Essen, Germany. He is committed to clinical care, clinical research and translational, lab-based research in sarcomas. He is Professor of Translational Oncology (Personalized Cancer Therapy) at the Dept. of Medical Oncology, University Hospital Essen as well as Director of the Sarcoma Center at the West German Tumor Center, one of the largest sarcoma programs in Europe. Dr Bauer has served as principal investigator in more than 50 clinical trials in bone, soft-tissue sarcomas, including gastrointestinal stromal tumors. His research group is focused on model development, resistance mechanisms to targeted treatments (primarily in GIST) and academic drug development. He is member of the steering committee of the German Sarcoma Study Group (AIO), member of the EORTC (STBSG) and board member of the German Sarcoma Foundation. He has in the past served as ESMO sarcoma track chair and is currently member of the sarcoma sub-committee. He is a regular reviewer for cancer-related journals and sarcoma meetings (CTOS, ESMO).
Two emerging and two established targets
Announcing the publication of survey results
An expert overview of the EMERALD subgroup analysis
Managing patients with nccRCC: guidelines, recommendations, and best practice
Risk factors, diagnostic tools and treatment options for different patient groups
Exploring emerging treatment strategies presented at SABCS 2024